CDC Group has invested in a $300 million fund from Adjuvant Capital focused on accelerating the development of medical innovations for historically overlooked public health challenges.
CDC invests in Adjuvant Capital’s $300m…
CDC Group has invested in a $300 million fund from Adjuvant Capital focused on accelerating the development of medical innovations for historically overlooked public health challenges.